Renaissance Technologies (RenTech)'s GMAB Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 2.27 M shares of Genmab A/S (GMAB) worth $81.07 M, representing 0.11% of the portfolio. First purchased in 2020-Q1, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in GMAB, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2020, adding 954,697 shares. Largest reduction occurred in Q3 2026, reducing 1.25 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Genmab A/S (GMAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Genmab A/S (GMAB) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | -1.25 M | Reduce 35.40% | 2.27 M | $35.68 |
| Q2 2026 | -896,700 | Reduce 20.31% | 3.52 M | $27.47 |
| Q1 2026 | +921,700 | Add 26.39% | 4.41 M | $26.83 |
| Q4 2025 | +671,307 | Add 23.79% | 3.49 M | $30.80 |
| Q3 2025 | +54,793 | Add 1.98% | 2.82 M | $30.67 |
| Q2 2025 | +504,400 | Add 22.30% | 2.77 M | $20.66 |
| Q1 2025 | +336,200 | Add 17.45% | 2.26 M | $19.58 |
| Q4 2024 | +139,722 | Add 7.82% | 1.93 M | $20.87 |
| Q3 2024 | +323,969 | Add 22.15% | 1.79 M | $24.38 |
| Q2 2024 | +103,859 | Add 7.64% | 1.46 M | $25.13 |
| Q1 2024 | -136,200 | Reduce 9.11% | 1.36 M | $29.91 |
| Q4 2023 | +320,800 | Add 27.33% | 1.49 M | $31.84 |
| Q3 2023 | +334,900 | Add 39.91% | 1.17 M | $35.27 |
| Q2 2023 | -210,500 | Reduce 20.06% | 839,100 | $0.04 |
| Q1 2023 | -141,100 | Reduce 11.85% | 1.05 M | $0.04 |
| Q4 2022 | +274,300 | Add 29.93% | 1.19 M | $0.04 |
| Q3 2022 | -63,800 | Reduce 6.51% | 916,400 | $32.13 |
| Q2 2022 | -108,300 | Reduce 9.95% | 980,200 | $32.49 |
| Q1 2022 | +14,100 | Add 1.31% | 1.09 M | $36.18 |
| Q4 2021 | +175,600 | Add 19.54% | 1.07 M | $39.56 |
| Q3 2021 | +13,900 | Add 1.57% | 898,800 | $43.70 |
| Q2 2021 | -107,400 | Reduce 10.82% | 884,900 | $40.83 |
| Q1 2021 | -318,900 | Reduce 24.32% | 992,300 | $32.83 |
| Q4 2020 | -352,000 | Reduce 21.16% | 1.31 M | $40.66 |
| Q3 2020 | +560,103 | Add 50.78% | 1.66 M | $36.61 |
| Q2 2020 | +954,697 | Add 643.33% | 1.1 M | $33.89 |
| Q1 2020 | +148,400 | New Buy | 148,400 | $21.19 |
Renaissance Technologies (RenTech)'s Genmab A/S Investment FAQs
Renaissance Technologies (RenTech) first purchased Genmab A/S (GMAB) in Q1 2020, acquiring 148,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Genmab A/S (GMAB) for 27 quarters since Q1 2020.
Renaissance Technologies (RenTech)'s largest addition to Genmab A/S (GMAB) was in Q2 2020, adding 1,103,097 shares worth $37.38 M.
According to the latest 13F filing for Q3 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 2,272,450 shares of Genmab A/S (GMAB), valued at approximately $81.07 M.
As of the Q3 2026 filing, Genmab A/S (GMAB) represents approximately 0.11% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Genmab A/S (GMAB) was 4,414,550 shares, as reported at the end of Q1 2026.